Pages that link to "Q39664147"

The following pages link to New developments in HCV therapy (Q39664147):

Displaying 18 items.

• Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy (Q26801207) (← links)
• Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6 (Q26828972) (← links)
• Viral quasispecies evolution (Q27013917) (← links)
• The new era of hepatitis C virus therapy (Q28086947) (← links)
• An Update on the Management of Chronic Hepatitis C: Consensus Guidelines from the Canadian Association for the Study of the Liver (Q30453975) (← links)
• The intraviral protein interaction network of hepatitis C virus (Q34418887) (← links)
• An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver (Q35100139) (← links)
• Antiviral therapy: old and current issues (Q38021181) (← links)
• The role of HCV proteins on treatment outcomes (Q38668968) (← links)
• Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: Does ethnicity matter? (Q39337505) (← links)
• Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France (Q40955157) (← links)
• Multiple strategies are required to address the information and support needs of gay and bisexual men with hepatitis C in Australia (Q41519160) (← links)
• New developments in the management of hepatitis C virus infection: focus on boceprevir (Q42200489) (← links)
• Detailed computational study of the active site of the hepatitis C viral RNA polymerase to aid novel drug design. (Q42263252) (← links)
• Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin (Q42694877) (← links)
• The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. (Q55288229) (← links)
• Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia. (Q64980481) (← links)
• Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19 (Q106996867) (← links)